Company intelligence / Profile preview
Verisfield
United Kingdomverisfield.gr ↗
- Ownership
- Private
- Employees
- ~75
- Development stage
- Other
01
Overview
Verisfield specializes in developing and marketing generic pharmaceutical products and those with improved or differentiated physicochemical characteristics. The company has launched products across many therapeutic categories, including innovative compositions protected by patents. Clinical activity includes Phase 3 trials for bioequivalence of generics such as clindamycin vaginal ovules versus branded comparators, with approved drugs like metronidazole hydrochloride on the market.[1][2][3][4]
- Therapeutic areas
- OtherInfectious Diseases
- Modalities
- Small molecules (primarily generics and improved formulations)[1][2][3]
- Industry
- Biotech
02
Drug pipeline
2 assets1 more asset in the full pipeline.
Beyond the preview
Go deeper on Verisfield.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Verisfield.